Trial
NCT03575195
Microbiota Intervention to Change the Response of Parkinson's Disease
Phase ISUSPENDEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
University of California, San Francisco
Collaborators
Nova Southeastern University; Gateway Institute for Brain Research
Condition
Parkinson Disease
Intervention
Rifaximin
Why stopped
Conducting an interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-04